Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics

Respirology

Volumn 13, Issue 7, 2008, Pages 1000-1007

  Kawayama, Tomotaka ^a   Kinoshita, Takashi ^a   Imaoka, Haruki ^a   Gauvreau, Gail M ^b   O'Byrne, Paul M ^b   Aizawa, Hisamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Airway inflammation; Asthma; Clinical allergy and immunology; Inhaled corticosteroid

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DISKUS; FLUTICASONE PROPIONATE; INTERLEUKIN 10; INTERLEUKIN 13; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ASTHMA; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATORY CELL; LYMPHOCYTE; MALE; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; ADULT; ANDROSTADIENES; ANTIGENS, CD; ASTHMA; BRONCHODILATOR AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; MALE; SEVERITY OF ILLNESS INDEX; SPUTUM; YOUNG ADULT;

EID: 54349114459     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01381.x     Document Type: Article

References (47)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, Updated November 2006 Accessed 20 May 2007] Available from URL: http://www.ginasthma.org
2. Corrigan CJ, Kay AB. Cd4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 1990 141 : 970 7.
3. Umetsu DT, Jabara HH, Dekruyff RH, Abbas AK, Abrams JS et al. Functional heterogeneity among human induced T cell clones. J. Immunol. 1988 140 : 4211 16.
4. Busse WW, Coffman RL, Gelfand EW, Kay AB, Rosenwasser LJ. Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am. J. Respir. Crit. Care Med. 1995 152 : 388 9.
5. Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+)t regulatory cells suppress naïve and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001 193 : 1295 302.
6. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. Cd4(+)cd25(high) regulatory cells in human peripheral blood. J. Immunol. 2001 167 : 1245 53.
7. Stephens LA, Mottet C, Mason D, Powrie F, Schuler G. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 2001 31 : 1247 54.
8. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cell with regulatory properties from human blood. J. Exp. Med. 2001 193 : 1303 10.
9. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000 101 : 455 8.
10. Robinson DS. The role of regulatory T lymphocytes in asthma pathogenesis. Curr. Allergy Asthma Rep. 2005 5 : 136 41.
11. Umetsu DT, Akbari O, Dekruyff RH. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol. 2003 112 : 480 7.
12. Hofstra CL, van Ark I, Hofman G, Kool M, Nijkamp FP et al. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J. Immunol. 1998 161 : 5054 60.
13. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003 4 : 330 6.
14. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002 3 : 135 42.
15. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J. Immunol. 2001 166 : 7282 9.
16. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000 192 : 303 10.
17. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994 1 : 405 13.
18. Green JM. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease. Am. J. Respir. Cell Mol. Biol. 2000 22 : 261 4.
19. Pandiyan P, Gartner D, Soezeri O, Radbruch A, Schulze-Osthoff K et al. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J. Exp. Med. 2004 199 : 831 42.
20. Kawayama T, Gauvreau GM, Yokoyama T, Richard RM, O'Conner TM et al. Different profiles of CTLA-4 positive CD25+CD4+ T cells in allergen-induced early and dual responders with asthma Abstract Am. J. Respir. Crit. Care Med. 2005 A289.
21. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin. Allergy 1977 7 : 235 43.
22. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992 47 : 25 9.
23. Pizzichini E, Pizzichini MMM, Efthimiadis A, Evans S, Morris MM et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 1996 154 : 308 17.
24. Yoshida M, Watson RM, Rerecich T, O'Byrne PM. Different profiles of T-cell IFN-gamma and IL-12 in allergen-induced early and dual responders with asthma. J. Allergy Clin. Immunol. 2005 115 : 1004 9.
25. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin. Allergy 1977 7 : 235 43.
26. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 2004 114 : 1425 33.
27. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995 80 : 707 18.
28. Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 1997 158 : 2042 9.
29. Hellings PW, Vandenberghe P, Kasran A, Coorevits L, Overbergh L et al. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur. J. Immunol. 2002 32 : 585 94.
30. Munthe-Kaas MC, Carlsen KH, Helms PJ, Gerritsen J, Whyte M et al. CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigm. J. Allergy Clin. Immunol. 2004 114 : 280 7.
31. Shi HZ, Mo XY, Zhong XN. Soluble CTLA-4 in sera of patients with bronchial asthma. J. Asthma 2005 42 : 133 9.
32. Chen X, Murakami T, Oppenheim JJ, Howard OM. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur. J. Immunol. 2004 34 : 859 69.
33. Xia M, Gasser J, Feige U. Dexamethasone enhances CTLA-4 expression during T cell activation. Cell Mol. Life Sci. 1999 55 : 1649 56.
34. Girndt M, Sester U, Kaul H, Hünger F, Köhler H. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. Transplantation 1998 66 : 370 5.
35. Dao Nguyen X, Robinson DS. Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J. Allergy Clin. Immunol. 2004 114 : 296 301.
36. Zhang Q, Qian FH, Liu H, Zhou LF, Huang M et al. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid. Chin. Med. J. (Engl.) 2008 121 : 205 12.
37. Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma Abstract Lancet 1998 352 (9122 113.
38. Matsumoto K, Inoue H, Fukuyama S, Tsuda M, Ikegami T et al. Decrease of interleukin-10-producing T cells in the peripheral blood of severe unstable atopic asthmatics. Int. Arch. Allergy Immunol. 2004 134 : 295 302.
39. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J et al. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 1996 97 : 1288 96.
40. Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J. Immunol. 1995 155 : 111 17.
41. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 2005 5 : 271 83.
42. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002 195 : 603 16.
43. Bosse Y, Thompson C, Stankova J, Rola-Pleszczynski M. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 2006 34 : 746 53.
44. Sagara H, Okada T, Okumura K, Ogawa H, Ra C et al. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J. Allergy Clin. Immunol. 2002 110 : 249 54.
45. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 2003 111 : 1293 8.
46. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 2006 12 : 99 106.
47. Chen Q, Rabach L, Noble P, Zheng T, Lee CG et al. IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 2005 174 : 2305 13.